DSCR1L1 Antibody (N-term)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- SPECIFICATION
- CITATIONS: 1
- PROTOCOLS
- BACKGROUND
Application
| FC, IHC-P, WB, E |
---|---|
Primary Accession | Q14206 |
Reactivity | Human, Mouse |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 21997 Da |
Antigen Region | 6-37 aa |
Gene ID | 10231 |
---|---|
Other Names | Calcipressin-2, Down syndrome candidate region 1-like 1, Myocyte-enriched calcineurin-interacting protein 2, MCIP2, Regulator of calcineurin 2, Thyroid hormone-responsive protein ZAKI-4, RCAN2, DSCR1L1, ZAKI4 |
Target/Specificity | This DSCR1L1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 6-37 amino acids from the N-terminal region of human DSCR1L1. |
Dilution | WB~~1:1000 IHC-P~~1:10~50 FC~~1:10~50 |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | DSCR1L1 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | RCAN2 |
---|---|
Synonyms | DSCR1L1, ZAKI4 |
Function | Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A. Could play a role during central nervous system development. |
Tissue Location | Expressed in fibroblasts, heart, brain, liver, and skeletal muscle but not in placenta, lung, kidney and pancreas |
Provided below are standard protocols that you may find useful for product applications.
Background
DSCR1L1 inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A. This protein may play a role during central nervous system development. Expression is detected in fibroblasts, heart, brain, liver, and skeletal muscle but not in placenta, lung, kidney and pancreas. Expression of both transcripts is upregulated by physiologic concentrations of the thyroid hormone triiodothyroxine.
References
Rothermel, B., et al., J. Biol. Chem. 275(12):8719-8725 (2000).
Fuentes, J.J., et al., Hum. Mol. Genet. 9(11):1681-1690 (2000).
Strippoli, P., et al., Genomics 64(3):252-263 (2000).
Miyazaki, T., et al., J. Biol. Chem. 271(24):14567-14571 (1996).
Cao, X., et al., Biochem. J. 367 (PT 2), 459-466 (2002) (): ().
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.